Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Joint strategy to benefit human and animal health
Syringe
The document under consultation outlines joint key priorities for the network.

Draft document outlines priorities for next five years

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released the 'EU Medicines Agencies Network Strategy to 2020'.

The document focuses on areas where collaboration within the network can make a difference to human and animal health in Europe in the next five years.

It is presented, for the first time, as a single strategy for the entire network - reflecting the need for a coordinated approach.

Arranged under four key themes, the strategy focusses on:

  • Human health
  • Animal and human health in relation to veterinary medicines,
  • Optimising the operation of the network
  • The global regulatory environment
It also includes a high level strategy to achieve these priorities.  

EMA and HMA say that the need to further strengthen the collaboration between the members of the network and work together towards achieving agreed goals has become more urgent in recent years.

"Europe faces the global threat of antibiotic resistance, and needs to be prepared for emerging epidemics," a spokesperson said.  "At the same time, the healthcare needs of patients in Europe are changing.  

"Advancements in science and medicine mean that new and more complex medicines are being developed, which may bring opportunities for personalised medicines and more treatments for rare diseases. Patients also require timely access to new, beneficial and safe medicines.

"The globalisation of the pharmaceutical industry means that greater collaboration with regulators beyond the European Union (EU) is essential to assure the supply of safe, effective and good quality medicines for humans and animals."

To view the Strategy visit www.ema.europa.eu. Stakeholders are invited to send their comments to EUnetworkstrategy@ema.europa.eu by 30 June 2015.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.